Pua, M.J. et al. 2022. Programmed Death Ligand 1 (PD-L1) Expression and its Association with Driver Mutations among Patients with Non-Small Cell Lung Cancer in a Private Tertiary Care Setting. PJP. 7, 2 (Dec. 2022), 36–45. DOI:https://doi.org/10.21141/PJP.2022.17.